Watson AMD - Search Results

1

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus.

Gill A, Gray SP, Jandeleit-Dahm KA, Watson AMD. Gill A, et al. Among authors: watson amd. Curr Diabetes Rev. 2019;15(5):349-356. doi: 10.2174/1573399814666180417121246. Curr Diabetes Rev. 2019. PMID: 29663893 Review.

2

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.

Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA. Soro-Paavonen A, et al. Diabetes. 2008 Sep;57(9):2461-9. doi: 10.2337/db07-1808. Epub 2008 May 28. Diabetes. 2008. PMID: 18511846 Free PMC article.

3

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA. Watson AM, et al. Diabetologia. 2010 Jan;53(1):192-203. doi: 10.1007/s00125-009-1540-3. Epub 2009 Oct 28. Diabetologia. 2010. PMID: 19862499

4

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Koïtka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ. Koïtka A, et al. Diabetologia. 2010 Mar;53(3):584-92. doi: 10.1007/s00125-009-1619-x. Epub 2009 Dec 3. Diabetologia. 2010. PMID: 19957160

5

The endothelin system and endothelin receptor antagonists.

Jandeleit-Dahm KA, Watson AM. Jandeleit-Dahm KA, et al. Curr Opin Nephrol Hypertens. 2012 Jan;21(1):66-71. doi: 10.1097/MNH.0b013e32834dde48. Curr Opin Nephrol Hypertens. 2012. PMID: 22123210 Review.

6

Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.

Watson AM, Gray SP, Jiaze L, Soro-Paavonen A, Wong B, Cooper ME, Bierhaus A, Pickering R, Tikellis C, Tsorotes D, Thomas MC, Jandeleit-Dahm KA. Watson AM, et al. Diabetes. 2012 Aug;61(8):2105-13. doi: 10.2337/db11-1546. Epub 2012 Jun 14. Diabetes. 2012. PMID: 22698914 Free PMC article.

7

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.

Watson AM, Olukman M, Koulis C, Tu Y, Samijono D, Yuen D, Lee C, Behm DJ, Cooper ME, Jandeleit-Dahm KA, Calkin AC, Allen TJ. Watson AM, et al. Diabetologia. 2013 May;56(5):1155-65. doi: 10.1007/s00125-013-2837-9. Epub 2013 Jan 24. Diabetologia. 2013. PMID: 23344731

8

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

Watson AM, Li J, Samijono D, Bierhaus A, Thomas MC, Jandeleit-Dahm KA, Cooper ME. Watson AM, et al. Atherosclerosis. 2014 Aug;235(2):444-8. doi: 10.1016/j.atherosclerosis.2014.05.945. Epub 2014 Jun 4. Atherosclerosis. 2014. PMID: 24945577

9

Linking RAGE and Nox in diabetic micro- and macrovascular complications.

Koulis C, Watson AMD, Gray SP, Jandeleit-Dahm KA. Koulis C, et al. Among authors: watson amd. Diabetes Metab. 2015 Sep;41(4):272-281. doi: 10.1016/j.diabet.2015.01.006. Epub 2015 Aug 29. Diabetes Metab. 2015. PMID: 26323666 Review.

10

The emerging role of NADPH oxidase NOX5 in vascular disease.

Jha JC, Watson AMD, Mathew G, de Vos LC, Jandeleit-Dahm K. Jha JC, et al. Among authors: watson amd. Clin Sci (Lond). 2017 May 1;131(10):981-990. doi: 10.1042/CS20160846. Clin Sci (Lond). 2017. PMID: 28473473 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page